论文信息 - 623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis - 字舞流文

623 – Ser-287, an Investigational Microbiome Therapeutic, Induces Widespread Transcriptional Changes Related to Clinical Remission in a Placebo-Controlled, Double-Blind Randomized Trial (Seres-101) in Patients with Active Mild-To-Moderate Ulcerative Colitis

J. Wortman | M. Henn | C. Desjardins | S. Simmons | Liyang Diao | Mauris C. Nnamani | Kevin D. Litcofsky | Asunción Martínez | E. O’Brien | D. Cook | B. Mcgovern | Sherry Weigand